|
Sep 2
|
Is Now An Opportune Moment To Examine Artivion, Inc. (NYSE:AORT)?
|
|
Jul 25
|
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
|
|
Jun 23
|
Artivion's (NYSE:AORT) Returns Have Hit A Wall
|
|
May 8
|
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
|
|
May 8
|
Shareholders Will Probably Hold Off On Increasing Artivion, Inc.'s (NYSE:AORT) CEO Compensation For The Time Being
|
|
May 6
|
Artivion Reports First Quarter 2024 Financial Results
|
|
Apr 29
|
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
|
|
Apr 22
|
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
|
|
Apr 19
|
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year
|
|
Apr 15
|
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
|
|
Apr 1
|
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 28
|
Are Medical Stocks Lagging Artivion (AORT) This Year?
|
|
Mar 12
|
Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?
|
|
Mar 6
|
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
|
|
Dec 6
|
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
|
|
Oct 19
|
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
|
|
Aug 3
|
Artivion Reports Second Quarter 2023 Financial Results
|